Medication Trolley

download Medication Trolley

of 24

  • date post

    21-Feb-2018
  • Category

    Documents

  • view

    218
  • download

    0

Embed Size (px)

Transcript of Medication Trolley

  • 7/24/2019 Medication Trolley

    1/24

    MEDICATION TROLLEY (WAD 2)

    Bil Ubat Dos Indikasi Kontraindikasi1 Tab.

    Acarbose

    100mg

    Initially 50 mg

    daily, increase to

    3 times daily upto 100 mg 3

    times daily. Ma

    !00 mg 3 times

    daily

    "on insulin

    dependent diabetes

    mellitus #"IDDM$%&en diet t&erapy is

    insu'cient

    "on insulin

    dependent diabetes

    mellitus #"IDDM$ in

    combination %it&

    eisting

    con(entional oral

    t&erapy %&ereglycaemic control is

    inade)uate

    *atients less t&an 1+

    years, c&ronic intestinal

    disorders associated%it& distinct

    disturbances o

    digestion and

    absorption,

    -onditions %&ic& may

    deteriorate as a result o

    increased intestinal gas

    ormation, pregnancy,

    lactation, se(ere renalimpairment

    ! Chloral

    !"ra#e

    $o"%&m

    200g' ml

    DU/ 0.5 2 1 g

    #ma ! g$ %it&

    plenty o %ater at

    bedtime

    *reoperati(e

    sedation

    ypersensiti(ity to

    c&loral &ydrate products

    -ardiac disease

    epatic or renal

    impairment

    *regnancy 4breast

    eeding

    *orp&yria

    astritis3 I* De+#rose

    Ah!"ro&s

    0, -'

    ccording to t&e

    needs o t&e

    patient

    6or parenteral

    replenis&ment o

    7uid and minimal

    carbo&ydrate

    calories as re)uired

    by t&e clinical

    condition o t&e

    patient

    *atients %it& anuria,

    diabetic coma,

    &yperglycaemia,

    intracranial or

    intraspinal

    &aemorr&age, delirium

    tremens in de&ydrated

    patients and glucose2

    galactose malabsorption

    syndrome.

    Do not administered

    simultaneously %it&

    blood t&roug& t&e same

    inusion set because o

    t&e possibility t&at

    pseudoagglutination o

    red cells may occur8 I* D%a/eam

    10mg'2ml

    9tatus

    epilepticus, by

    slo% I: 5210e(ery 10215

    9tatus epilepticus

    9keletal muscle

    spasmniety disorders

    ;espiratory depression

    cute pulmonary

    insu'ciency9e(ere &epatic

  • 7/24/2019 Medication Trolley

    2/24

    minute #rate not

    more t&an 5

    mg

  • 7/24/2019 Medication Trolley

    3/24

    e(ery 328 &ours5 I*. D%go+%

    0.mg' 2ml

    ;apid

    digitilisation

    DU/ 4 -I/D

    o(er 10 years,

    initially 0.?5 2 1.5mg, ollo%ed by

    !50 mcg > &ourly

    until digitilisation

    is complete

    eart ailure %it&

    atrial @brillation

    9upra(entricular

    arr&yt&mias

    #particularly atrial@brillation$

    :entricular @brillation,

    (entricular tac&ycardia

    ecept in certain cases,

    digitalis toicity, beriberi

    &eart disease,&ypersensiti(ity to

    digoin, some cases o

    &ypersensiti(e carotid

    sinus syndrome

    > I*.

    Dobam%e

    20mg'2ml

    Initial 0.521

    mcg

  • 7/24/2019 Medication Trolley

    4/24

    c&loride and

    detrose inection

    or 5C detrose I:

    inusion,

    ypertension o

    pregnancyA !0mgper &our doubled

    e(ery 30 min to

    ma 1>0 mg per

    &our I*

    L%goca%e

    100mg'ml

    /ocal

    anest&esia

    DU/ Maimum

    !00 mgA -I/D

    Maimum 30

    mg

  • 7/24/2019 Medication Trolley

    5/24

    I:. Ma !00 F 300

    mg< &our

    -I/D 0.+ F 1

    mg

    &our and t&enollo%ed by an oral

    9e(ere nausea and

    (omiting

    :ertigo < labyrint&ine

    disorder

    -"9 depression or coma

    Bone marro% depression

    *&aeoc&romocytoma

    ypersensiti(ity to

    p&enot&ia=ines

  • 7/24/2019 Medication Trolley

    6/24

    dose.

    "ot recommended in

    c&ildren

    -omatose states

    -ardio(ascular collapse

    1> Ra%#%"%e

    0mg' 2ml

    %*ec#%o

    1$ DU/ slo% I:

    inection o 50mg

    diluted to !0ml andgi(en o(er at least

    ! minutes. Maybe

    repeated e(ery >2+

    &ours or I: inusion

    at rate o !5

    mg2+ &ours inter(als

    or IM

    -I/D 1mg &ours as re)uired

    Ma 8 g daily

    Use in c&ildren notrecommended

    Mild to moderate

    pain

    astric and duodenal

    ulcers

    aemorr&agic diat&esis

    ypersensiti(ity toaspirin or ot&er "9IDs

    -&ildren under 1! years

    old

    ypersensiti(ity #attack

    o ast&ma, angioedema,

    urticaria or r&itinis$

    *regnancy # t&ird

    trimester$

    *atient %it& &aemop&ilia

    or &aemorr&agicdisorder

    out

  • 7/24/2019 Medication Trolley

    7/24

    9e(ere renal or &epatic

    impairment

    lactation1 !osc%e N

    3!lbrom%"

    e 10 mgTable# (B)

    rade "ame

    Buscopan

    DU/ 102!0 mg 328

    times daily.

    -I/D >21! years

    10 mg 3 times

    daily

    astrointestinal

    tract and genito2

    urinary tract spasm,dyskinesia o t&e

    biliary system

    Gbstructi(e disease o

    t&e gastrointestinal or

    urinary tract, narro%2angle glaucoma, cardiac

    tac&yarr&yt&mias,

    myast&enia gra(is,

    prostatic &ypertrop&y

    %it& urinary retention!0 Ib&ro7e

    200 mg

    Table# (B)

    rade "ame

    Bruen

    DU/ !00 2 800

    mg 3 times daily

    ater ood,

    maimum. !.8 g

    daily -I/D !0230 mg

  • 7/24/2019 Medication Trolley

    8/24

    !0 mgA -I/D less

    t&an 15 years

    0.1! mg

    times a day beore

    meals.

    -I/D o(er > years

    one tablet to be

    taken 328 times a

    day

    eartburn,

    dyspepsia

    ypersensiti(ity to

    antacids,

    &ypop&osp&ataemia

    !8 4rolase

    Table#( B$

    rade "ame

    *apase

    ! tablet 8 times

    daily

    Gedema and

    in7ammation in

    conunction %it&

    ot&er p&ysical or

    c&emot&erapeutic

    measures

    Blood clotting disease.

    !5 4rochlorera

    /%e Malea#e

    mg Table#

    (B$rade "ame

    9temetil

    Inection IM 1!.5 mg

    stat and repeated

    i necessary ater >

    &ours

    or

    orally !0 mg stat

    ollo%ed by 10 mg

    ater ! &ours.

    *re(ention 5 2 10

    mg ! 2 3 times a

    day.

    -I/D #o(er 10 kg

    only$ !50 mcg

  • 7/24/2019 Medication Trolley

    9/24

    se(eral %eeks to 5

    2 10mg daily. "ot

    recommended in

    c&ildren

    increased risk o

    etrapyramidal

    reactions

    !> 4arace#amol00 mg

    Table# (-$

    rade "ame

    *anadol

    DU/ 500 2 1000mg e(ery 8 2 >

    &ours, maimum o

    8 g daily

    Mild to moderatepain and pyreia

    "ep&ropat&y

    !? Tr%rol%"%e

    Cl 2. mg

    a"

    4se&"oehe

    "r%e Cl 80mg Table#

    (B $

    rade "ame

    ctied

    DU/ !.5 mg e(ery

    8 2 > &oursA

    maimum dose 10

    mg 2 1! years

    1.!5 mg e(ery 8 2

    > &oursA maimum

    dose 5 mg!5

    mg e(ery 8 2 >

    &oursA maimum

    dose !.5 mg years 0.3+

    mg e(ery 8 2 >

    &oursA maimum

    dose 3.?88

    mg &oursA maimum

    dose 1.!5 mg

  • 7/24/2019 Medication Trolley

    10/24

    mg

  • 7/24/2019 Medication Trolley

    11/24

    minutes beore

    surgeryA

    E/DE;/J 1 2 1.5

    mg

  • 7/24/2019 Medication Trolley

    12/24

    patients, 80mg

    e(ery !8 &ours or

    at least > days

    until patient

    ambulant, ma 18

    days.reatment o D: or

    pulmonary

    embolism, 1.5

    mg

  • 7/24/2019 Medication Trolley

    13/24

    I patient needs to

    undergo *-I,

    unractionated

    &eparin to be

    admin as per local

    practice protocol,taking into account

    t&e patientOs

    bleeding risk and

    time o last dose o

    ondaparinu.

    6ondaparinu may

    be restarted no

    earlier t&an ! &r

    ater s&eat&

    remo(al. iii$ DU/ more t&an

    1+ years !.5 mg

    once dailyA @rst

    dose to be gi(en I:

    #directly t&roug&

    an eisting I: line

    or as inusion in !5

    or 50 ml o 0.C

    saline o(er 12!

    min$, subse)uentdoses to be gi(en

    9-. reatment to

    be initiated as

    soon as diagnosis

    is made and

    continued up to a

    ma o + days or

    until &ospital

    disc&arge,

    %&ic&e(er comesearlier. I patient

    needs to undergo

    non2primary *-I,

    unractionated

    &eparin to be

    admin as per local

    practice protocol,

    taking into account

    t&e patientOs

    bleeding risk andtime o last dose o

    segment ele(ation

    myocardial inarction

    #9EMI$ in patients

    managed %it&

    t&rombolytics or are

    not recei(ing ot&erorms o reperusion

    t&erapy

  • 7/24/2019 Medication Trolley

    14/24

    ondaparinu.

    6ondaparinu may

    be restarted no

    earlier t&an 3 &r

    ater s&eat&

    remo(al35 :l!cer!l

    Tr%%#ra#e 0

    mg'10 ml

    I*ec#%o

    ;:l!cer!l

    Tr%%#ra#e 2

    mg' ml

    I*ec#%o

    Initial 5 mcg

  • 7/24/2019 Medication Trolley

    15/24

    single 8 mg once

    B* acceptability

    &as been

    demonstrated. 8